BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26969892)

  • 21. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
    Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
    Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methionine adenosyltransferases in liver cancer.
    Murray B; Barbier-Torres L; Fan W; Mato JM; Lu SC
    World J Gastroenterol; 2019 Aug; 25(31):4300-4319. PubMed ID: 31496615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methionine adenosyltransferases in cancers: Mechanisms of dysregulation and implications for therapy.
    Maldonado LY; Arsene D; Mato JM; Lu SC
    Exp Biol Med (Maywood); 2018 Jan; 243(2):107-117. PubMed ID: 29141455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases.
    Pérez C; Pérez-Zúñiga FJ; Garrido F; Reytor E; Portillo F; Pajares MA
    PLoS One; 2016; 11(8):e0161672. PubMed ID: 27548429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSNK2A1-mediated MAX phosphorylation upregulates HMGB1 and IL-6 expression in cholangiocarcinoma progression.
    Yang B; Zhang J; Wang J; Fan W; Barbier-Torres L; Yang X; Justo MAR; Liu T; Chen Y; Steggerda J; Ramani K; Lu SC; Yang H
    Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37347224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
    Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
    Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells.
    Kitagawa K; Moriya K; Kaji K; Saikawa S; Sato S; Nishimura N; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
    Wahlström T; Belikov S; Arsenian Henriksson M
    Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive base substitution rules that determine the binding and transcriptional specificity of Maf recognition elements.
    Yamamoto T; Kyo M; Kamiya T; Tanaka T; Engel JD; Motohashi H; Yamamoto M
    Genes Cells; 2006 Jun; 11(6):575-91. PubMed ID: 16716189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis.
    Tomasi ML; Iglesias-Ara A; Yang H; Ramani K; Feo F; Pascale MR; Martínez-Chantar ML; Mato JM; Lu SC
    Gastroenterology; 2009 Mar; 136(3):1025-36. PubMed ID: 18983843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methionine adenosyltransferase II serves as a transcriptional corepressor of Maf oncoprotein.
    Katoh Y; Ikura T; Hoshikawa Y; Tashiro S; Ito T; Ohta M; Kera Y; Noda T; Igarashi K
    Mol Cell; 2011 Mar; 41(5):554-66. PubMed ID: 21362551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
    Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
    J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TCF21 inhibits tumor-associated angiogenesis and suppresses the growth of cholangiocarcinoma by targeting PI3K/Akt and ERK signaling.
    Duan HX; Li BW; Zhuang X; Wang LT; Cao Q; Tan LH; Qu GF; Xiao S
    Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G763-G773. PubMed ID: 30920845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAFG is a transcriptional repressor of bile acid synthesis and metabolism.
    de Aguiar Vallim TQ; Tarling EJ; Ahn H; Hagey LR; Romanoski CE; Lee RG; Graham MJ; Motohashi H; Yamamoto M; Edwards PA
    Cell Metab; 2015 Feb; 21(2):298-311. PubMed ID: 25651182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
    Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
    Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-128 Is Implicated in Stress Responses by Targeting MAFG in Skeletal Muscle Cells.
    Caggiano R; Cattaneo F; Moltedo O; Esposito G; Perrino C; Trimarco B; Ammendola R; Faraonio R
    Oxid Med Cell Longev; 2017; 2017():9308310. PubMed ID: 29138682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of CCAAT/enhancer binding protein-beta (C/EBPbeta) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression.
    Ikeda R; Nishida T; Watanabe F; Shimizu-Saito K; Asahina K; Horikawa S; Teraoka H
    Int J Biochem Cell Biol; 2008; 40(9):1956-69. PubMed ID: 18346930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of trophoblast cell surface antigen 2 enhances proliferation and migration in liver fluke-associated cholangiocarcinoma.
    Sawanyawisuth K; Tantapotinan N; Wongkham C; Riggins GJ; Kraiklang R; Wongkham S; Puapairoj A
    Ann Hepatol; 2016; 15(1):71-81. PubMed ID: 26626643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor-Stroma Paracrine Signaling.
    Lobe C; Vallette M; Arbelaiz A; Gonzalez-Sanchez E; Izquierdo L; Pellat A; Guedj N; Louis C; Paradis V; Banales JM; Coulouarn C; Housset C; Vaquero J; Fouassier L
    Hepatology; 2021 Dec; 74(6):3194-3212. PubMed ID: 34297412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
    Si J; Yu X; Zhang Y; DeWille JW
    Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.